Suannutra seals US distribution rights for TetraSOD
Suannutra USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino S L to provide TetraSOD for the North American market
Search fresh public links, source activity, and post angles for Biosneds Apigensol.
Fresh curated links around BioSNEDS ApigenSol are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Suannutra USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino S L to provide TetraSOD for the North American market
Researchers at the University of Pennsylvania developed ApexGO, an AI-powered system that optimizes antimicrobial peptides, rapidly improving antibiotic candidates and identifying...
- - • Next-generation plant-derived true exosomes supporting long-term�skin regeneration, resilience, and vitality - • 100% natural origin ingredient combining...
An algorithm for assessing protein aggregation and designing more soluble proteins could help overcome a bottleneck in biologics production. The new, improved software helps manufa...
New clinical trial in elderly adults and growing distributor network signal deepening commitment to European nutraceutical market NEW CANAAN, Conn., April 24, 2026 /PRNewswire-PRWe...
TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...
In a partnership with Syngenta, early laboratory testing demonstrated the activity of novel bioactive ingredients, developed with Biotalys’ AGROBODY technology, against a specific...
Biobest's new Aphidoletes-System packaging supports faster population build-up of Aphidoletes aphidimyza. This improves longevity and fecundity for more effective and sustainable a...
The company has rallied from an earlier setback in obesity thanks to early progress for a drug targeting “NLRP3,” an inflammasome linked to a variety of health conditions.
David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...
The product will be marketed and commercialised in the United States by Apotex Corp., the ANDA applicant
Syngenta unveiled the global launch of Virestina technology active ingredient metproxybicyclone after Argentina became the first country in the world to approve the technology It i...
Botanix Pharmaceuticals / Sofdra Launch Anonymous (not verified) Mon, 04/13/2026 - 05:05 field_thread_url https://cafepharma.com/boards/threads/botanix-pha...
After axing its lead obesity asset last year, BioAge Labs has turned its attention to attacking inflammation in its pursuit of treatments for aging-related illnesses.
Syfovre Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/syfovre.690248/ board na...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.